Axsome Therapeutics Inc (AXSM)
99.56
-0.92
(-0.92%)
USD |
NASDAQ |
Dec 04, 16:00
99.40
-0.16
(-0.17%)
After-Hours: 20:00
Axsome Therapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| December 04, 2024 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Repligen Corp | -- |
| Pfizer Inc | 34.09 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
PE Ratio Related Metrics
| PS Ratio | 14.01 |
| PEG Ratio | -0.3454 |
| Price to Book Value | 51.94 |
| Price | 99.56 |
| Earnings Yield | -6.56% |
| Market Cap | 4.825B |
| PEGY Ratio | -0.3454 |